Changes in Hemostasis System in Outbred Female Mice with Cisplatin-Induced Procoagulant Status.
Procoagulant status was modeled in outbred female mice by single injection of cisplatin in a maximum tolerated dose and hemostasis parameters monitored over 30 days by methods of coagulogram and low-frequency piezothromboelastography (global test). Monitoring revealed waveform changes in the hemostatic potential: the structural and chronometric hypercoagulation recorded starting from the first day and attaining its maximum on days 5-7 was followed by hypocoagulation and returned to normocoagulation on day 30. This pattern reflects prolonged effect of cisplatin: formation of severe dysfunction of the endothelium providing the main anticoagulant pool of hemostasis (day 1) aggravated by disturbances of the plastic functions of the liver (days 15-20), and recovery (days 20-30).
['Filonova|M V|MV|', 'Fedorova|E P|EP|', 'Churin|A A|AA|', 'Kotlovskaya|L Yu|LY|', "Solov'ev|M A|MA|", 'Udut|V V|VV|']
D000818:Animals D021461:Animals, Outbred Strains D002945:Cisplatin D003029:Coagulants D004211:Disseminated Intravascular Coagulation D004730:Endothelium, Vascular D005260:Female D006487:Hemostasis D008099:Liver D051379:Mice D013916:Thrombelastography
cisplatin low-frequency piezothromboelastography hemostatic potential endothelial dysfunction outbred mice